605116.SS

Aurisco Pharmaceutical Co.,Ltd. [605116.SS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

605116.SS Stock Summary

Top 10 Correlated ETFs

605116.SS

Top 10 Correlated Stocks

605116.SS

In the News

605116.SS Financial details

Company Rating
-
Market Cap
8.9B
Income
257.05M
Revenue
1.16B
Book val./share
-
Cash/share
-
Dividend
0.16
Dividend %
0.65%
Employees
1.36K
Optionable
No
Shortable
Yes
Earnings
29 Aug 2023
P/E
40.93
Forward P/E
-
PEG
8.14
P/S
8.55
P/B
5.63
P/C
-
P/FCF
-1288.46
Quick Ratio
1.88
Current Ratio
3.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.63
EPS next Y
-
EPS next Q
-
EPS this Y
26.19%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.88%
Revenue last 5Y
11.87%
Revenue Q/Q
47.65%
EPS Q/Q
183.33%
-
-
-
-
SMA20
-0.93%
SMA50
5.94%
SMA100
-0.89%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
15%
ROC
0.15%
Gross Margin
56%
Oper. Margin
25%
Profit Margin
22%
Payout
26%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
17.33-28.13
52W High
-25.82%
52W Low
+22.18%
RSI
47.46
Rel Volume
0.73
Avg Volume
1.61M
Volume
1.18M
Perf Week
-3.31%
Perf Month
-3.84%
Perf Quarter
-4.99%
Perf Half Y
-10.09%
-
-
-
-
Beta
-0.276
-
-
Volatility
0.28%, 0.66%
Prev Close
-0.91%
Price
20.77
Change
-3.66%

605116.SS Financial Performance

605116.SS Dividend History

605116.SS Frequently Asked Questions

What is Aurisco Pharmaceutical Co.,Ltd. stock symbol ?

Aurisco Pharmaceutical Co.,Ltd. is a CN stock and trading under the symbol 605116.SS

What is Aurisco Pharmaceutical Co.,Ltd. stock quote today ?

Aurisco Pharmaceutical Co.,Ltd. stock price is $20.77 today.

Is Aurisco Pharmaceutical Co.,Ltd. stock public?

Yes, Aurisco Pharmaceutical Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
3V64.DE
EMBASSY.NS
DHR-PB
CMC.DE
BRH.DE
Top Correlated ETFs
SVR.TO
ABEQ
SLV
SIVR
SBT.TO
Top Correlated Stocks
002001.SZ
ADM
603713.SS
MNS.TO
688008.SS
Similar Market Cap
ALSN
600959.SS
600597.SS
300463.SZ
600751.SS

Company Profile

Healthcare Biotechnology
  • Volume Average 1.61M
  • Market Capitalization 8.9B
  • Employee 1.36K
  • CEO Mr. Dingjun Chu
  • Headquarters Tiantai,CN
  • IPO Date 2020-09-21
  • Website https://www.aurisco.com

Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.